Literature DB >> 31950326

Low-oxygen and knock-out serum maintain stemness in human retinal progenitor cells.

Deepti Singh1, Pierre C Dromel1,2, Michael Young3.   

Abstract

Using stem and progenitor cells to treat retinal disorders holds great promise. Using defined culture conditions to maintain the desires phenotype is of utmost clinical importance. We cultured human retinal progenitor cells (hRPCs) in different conditions: such as normoxia (20% oxygen), and hypoxia (5% oxygen) with and without knock-out serum replacement (KOSR) to evaluate its effect on these cells. KOSR is known nutrient supplement often used to replace bovine serum for culturing embryonic or pluripotent stem cells, especially those destined for clinical applications. The purpose of this study was to identify the impact of different environmental and chemical cues to determine if this alters the fate of these cells. Our results indicate that cells cultured with or without KOSR do not show significant differences in viability, but that the oxygen tension can significantly change their viability (higher in hypoxia than normoxia). However, cells with KOSR in hypoxia condition expressed significantly higher stemness markers such as C-myc and Oct4 (31.20% and 13.44% respectively) in comparison to hRPCs cultured in KOSR at normoxia (12.07% and 4.05%). Furthermore, levels of markers for retinal commitment such as rhodopsin were significantly lower in the KOSR supplemented cells in hypoxia culture compared to normoxia. KOSR is known to improve proliferation and maintain stemness of embryonic cells and our experiments suggest that hRPCs maintain their proliferation and stemness characteristics in hypoxia with KOSR supplement. Normoxia, however, results in mature cell marker expression, suggesting a profound effect of oxygen tension on these cells.

Entities:  

Keywords:  Flow cytometer; Human retinal progenitor cells; Hypoxia; Stemness

Mesh:

Substances:

Year:  2020        PMID: 31950326     DOI: 10.1007/s11033-020-05248-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors.

Authors:  E B Lavik; H Klassen; K Warfvinge; R Langer; M J Young
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

2.  Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors.

Authors:  Henry Klassen; Boback Ziaeian; Ivan I Kirov; Michael J Young; Philip H Schwartz
Journal:  J Neurosci Res       Date:  2004-08-01       Impact factor: 4.164

Review 3.  Development of human embryonic stem cell therapies for age-related macular degeneration.

Authors:  Amanda-Jayne F Carr; Matthew J K Smart; Conor M Ramsden; Michael B Powner; Lyndon da Cruz; Peter J Coffey
Journal:  Trends Neurosci       Date:  2013-04-17       Impact factor: 13.837

4.  Effect of gene therapy on visual function in Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Alexander J Smith; Susie S Barker; Scott Robbie; Robert Henderson; Kamaljit Balaggan; Ananth Viswanathan; Graham E Holder; Andrew Stockman; Nick Tyler; Simon Petersen-Jones; Shomi S Bhattacharya; Adrian J Thrasher; Fred W Fitzke; Barrie J Carter; Gary S Rubin; Anthony T Moore; Robin R Ali
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

5.  Safety and efficacy of gene transfer for Leber's congenital amaurosis.

Authors:  Albert M Maguire; Francesca Simonelli; Eric A Pierce; Edward N Pugh; Federico Mingozzi; Jeannette Bennicelli; Sandro Banfi; Kathleen A Marshall; Francesco Testa; Enrico M Surace; Settimio Rossi; Arkady Lyubarsky; Valder R Arruda; Barbara Konkle; Edwin Stone; Junwei Sun; Jonathan Jacobs; Lou Dell'Osso; Richard Hertle; Jian-xing Ma; T Michael Redmond; Xiaosong Zhu; Bernd Hauck; Olga Zelenaia; Kenneth S Shindler; Maureen G Maguire; J Fraser Wright; Nicholas J Volpe; Jennifer Wellman McDonnell; Alberto Auricchio; Katherine A High; Jean Bennett
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

6.  Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation.

Authors:  Stephen Redenti; William L Neeley; Santiago Rompani; Sunita Saigal; Jing Yang; Henry Klassen; Robert Langer; Michael J Young
Journal:  Biomaterials       Date:  2009-04-09       Impact factor: 12.479

7.  Molecular characterization of human retinal progenitor cells.

Authors:  Scott Schmitt; Unber Aftab; Caihui Jiang; Stephen Redenti; Henry Klassen; Erik Miljan; John Sinden; Michael Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-24       Impact factor: 4.799

8.  Growth kinetics and transplantation of human retinal progenitor cells.

Authors:  Unber Aftab; Caihui Jiang; Budd Tucker; Ji Yeon Kim; Henry Klassen; Erik Miljan; John Sinden; Michael Young
Journal:  Exp Eye Res       Date:  2009-06-12       Impact factor: 3.467

9.  Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.

Authors:  Anthony Vugler; Amanda-Jayne Carr; Jean Lawrence; Li Li Chen; Kelly Burrell; Andrew Wright; Peter Lundh; Ma'ayan Semo; Ahmad Ahmado; Carlos Gias; Lyndon da Cruz; Harry Moore; Peter Andrews; James Walsh; Peter Coffey
Journal:  Exp Neurol       Date:  2008-09-27       Impact factor: 5.330

Review 10.  Regenerative medicine in the retina: from stem cells to cell replacement therapy.

Authors:  Julia Oswald; Petr Baranov
Journal:  Ther Adv Ophthalmol       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.